Narva clinics has been acquired by Narva Åderbråckscenter AB

The founder and some key employees of Åderbråcksspecialisterna Narva Kirurg Center AB and Narva Derma Center AB (Narva) have completed an MBO.

Åderbråcksspecialisterna Narva Kirurg Center and Narva Derma Center are engaged in varicose vein treatments and aesthetic skincare. Founded in 2012, Narva is a leading Swedish pioneer in modern endovenous treatments for varicose veins. Most of its income comes from private paying patients but Narva is also one of only two market players contracted by the region of Stockholm to carry out varicose vein treatments. Based in Stockholm, Narva also operates several clinics around the country.

Narva Åderbråckscenter AB is a newly created company owned by Narva’s founder together with key employees. The new shareholders will develop Narva’s business plan in order to take advantage of the market opportunities within privately funded healthcare.

Oaklins’ team in Sweden acted as financial advisor in this transaction.

Uppdrag

Företagsförsäljning

Parter

“Together with Oaklins’ team in Sweden, we have carefully worked through the various strategic options at hand for a change of ownership in Narva. The team’s financial and strategic expertise, as well as their experience in the healthcare sector, have been crucial when evaluating the various alternatives.”

Stefan Nydahl

Founder, Narva Åderbråckscenter AB

Prata med transaktionsteamet

Adel Koubaa

Managing Partner

Stockholm, Sverige
Oaklins Sweden

Se profil Kontakta oss

Lars Gustafsson

Partner

Stockholm, Sverige
Oaklins Sweden

Se profil Kontakta oss

Relaterade transaktioner

Cerbios-Pharma has been acquired by HAS Healthcare

Hälsovård

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Lär dig mer

Pharma-Skan & Skan-Medic have been acquired by Brygge Partners

Hälsovård

Pharma-Skan & Skan-Medic have been acquired by Brygge Partners

Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.

Lär dig mer

The Canton of Solothurn had a valuation report prepared for its hospitals

Hälsovård

The Canton of Solothurn had a valuation report prepared for its hospitals

The Canton of Solothurn is the owner of Solothurner Spitäler AG (soH), with its three hospitals in Solothurn, Olten and Dornach.

Lär dig mer